If you can't see the images in this email, please click here.

April 14, 2015

Advocacy achievement ends reimbursement uncertainty, stops CMS proposal to end global period codes

In a momentous victory for dermatologists and the entire house of medicine, the Senate passed the Medicare Access and CHIP Reauthorization Act (H.R.2), clearing the way for a law that permanently repeals the sustainable growth rate (SGR) formula and stops a CMS proposal to eliminate global periods.

The AADA applauds the bipartisan, bicameral work of lawmakers who recognized that the SGR was beyond repair. The perennial fixes and patches posed great harm to patient access to care and detracted from meaningful payment reform efforts.

The AADA’s advocacy efforts helped secure provision within the bill that preserves 10 and 90-day global codes – a significant accomplishment that prevents both reimbursement cuts and extra co-pays for patients. The President is expected to sign the bill into law very soon.

The unwavering support of the AADA membership in the form of thousands of emails, letters, calls and in-person visits to Capitol Hill each year helped secure this legislative milestone.

As the law enters the implementation phase, the AADA remains vigilant it its mission ensure that future public policies consider the unique needs of dermatologists and their patients. Particularly, as new payment and care models are developed and debated, the AADA will continue to fight to preserve and protect the specialty. The AADA will continue to bring you the latest as the law moves forward.

If you no longer wish to receive future emails from the Academy, please click here.

American Academy of Dermatology Association
1445 New York Avenue, NW, Suite 800
Washington, DC 20005
Website: www.aad.org